CZ ATC L01CB01 · updated 2 Nov 2026
Etoposide shortage in Czechia
Is there an Etoposide shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Etoposide products are reported short in Czechia, the first since 5 Jan 2026. The company estimate for the return is 30 Nov 2026 (latest 29 Jan 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Belgium, Switzerland, Japan, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ETOPOSIDE TEVA 20MG/ML 20MG/ML INF CNC SOL 1X10ML | Teva Pharmaceuticals CR, s.r.o., Praha | 5 Jan 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | ETOPOSID EBEWE 20MG/ML 20MG/ML INF CNC SOL 1X10ML | EBEWE Pharma Ges.m.b.H Nfg.KG, Unterach | 27 May 2026 | 11 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | ETOPOSIDE ACCORD 20MG/ML 20MG/ML INF CNC SOL 1X12,5ML | Accord (Intas) | 8 Oct 2026 | 29 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.